YouScript

“Greater than 99% of people have at least one [genetic] variation that impacts, on average, over 10 commonly prescribed medications that a patient will take,” said Kristine Ashcraft, the President and Founder of YouScript. Read more into Kristine's insights in the final installment of Pharmacy Practice News's 7-part series where industry experts express the importance of crossing barriers to pharmacogenomic implementation in health systems. https://lnkd.in/geS2WtH5 #KristineAshcraft #PharmacyPracticeNews #PPN #PGx

"PGx testing also illustrates the problem of treating conditions in silos rather than holistically. When providers do order PGx testing, they often focus solely on mental health medications, overlooking how the same liver enzymes can affect responses to medications in other areas like cardiovascular care, pain management, and cancer treatment." - Kristine Ashcraft, President and Founder, YouScript Kristine joined Stephanie Greer, CEO of Akin Mental Health for an interview titled "Healing a Broken Mental Health System: Kristine Ashcraft of YouScript on 5 Things That Can Be Done To Fix Our Broken Mental Health System". Read the full interview in Authority Magazine: https://lnkd.in/gw5pCqfU #MentalHealth #Pharmacogenomics #PGx

Welcome to YouScript Insights, a newsletter with information about all things YouScript and the Aranscia brands. Keep up with our work in research, publications, media articles, press releases, and more! #YouScriptInsights

🎙 Tune in today and tomorrow at 2pm Eastern to Healthcare de Jure, a part of the Healthcare NOW Radio radio network: https://lnkd.in/ebkKk_p Kristine Ashcraft, President and Founder of YouScript, joined host Matt Fisher to discuss all things pharmacogenomics - from what it is and how it works to legislation and coverage for testing across the nation. If you can't tune in this week, we'll let you know when the episode goes on demand!

"Integrating PGx testing is not just a matter of improving patient care; it’s also a crucial step in mitigating medical liability risk. Medication-related harm ranks among the top three causes of malpractice claims, with a staggering 75% resulting in paid indemnity." - Kristine Ashcraft, President and Founder of YouScript Read Kristine's article in Healthcare Business Today to learn how health systems can avoid medication-related harm by implementing broad PGx testing. https://lnkd.in/gHgYEdr2 #PGx #Pharmacogenomics #KristineAshcraft #HBT #RiskMitigation #RiskReduction

YouScript is excited to announce "PGx Bytes" - a series of short discussions that will cover important topics across the healthcare space. Watch episode 1 here: https://lnkd.in/gzGYqhDZ Host Kristine Ashcraft, President and Founder of YouScript is joined by Houda Hachad, Vice President of Clinical Operations at Aranscia. They discuss #pharmacogenomics, the importance of reviewing both drug and gene interactions, and the impacts on #polypharmacy. #PGxBytes #HoudaHachad #KristineAshcraft

Congratulations to our President and Founder, Kristine Ashcraft, recipient of STRIPE's 2024 Annual Double Helix Award! #PGx #pharmacogenomics #STRIPEcc

"PGx testing in mental health has been demonstrated to shorten the time to remission, reduce pharmacy costs, and decrease psychiatric hospital stays." - Kristine Ashcraft, President and Founder of YouScript, an Aranscia company, in HIT Consultant Media.   When typical mental health treatments often involve trial and error prescribing, the time to treatment can be detrimental. #PGx testing before prescribing can help get the patient or resident on the correct medication sooner, saving time, money, and lives. #WorldMentalHealthDay #BeStigmaFree #StopTheStigma #MentalHealthAwareness

In honor of Mental Illness Awareness Week, our team at YouScript wants to take a moment to highlight the importance of #pharmacogenomics when it comes to mental health. Mental disorders, ranging from anxiety to depression to schizophrenia and PTSD, are incredibly common, yet often not discussed. Many prescriptions for these disorders have pharmacogenomic implications and guidelines, as defined by organizations like the FDA and CPIC. A simple #PGx test can help reduce trial-and-error prescribing. Learn more about Mental Illness Awareness Week from NAMI at nami.org/MIAW #MentalIllnessAwarenessWeek #NAMIStigmaFree #StigmaFree

"If four full 737s were crashing daily resulting in total loss of life, there would be a public outcry and immediate governmental intervention. Yet, we lose an equivalent number of people daily — 275,000 American lives annually — to adverse drug events (ADEs)." - Kristine Ashcraft, Founder and President, YouScript Read Kristine's article in MedCity News to learn the importance of biomarker legislation, education, and advocacy to address the barriers to PGx testing. https://lnkd.in/gyJUFidi #pharmacogenomics #PGx #biomarkerlegislation